Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RIGL | NKTR | KALV | ||
| Company | Rigel Pharmaceuticals | Nektar Therapeutics | Kalvista Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 44.47 | 43.61 | 15.62 | ||
| High | 44.47 | 44.91 | 15.63 | ||
| Low | 42.68 | 43.01 | 14.91 | ||
| Latest | 44.01 | 44.49 | 15.17 | ||
| Change | -0.63 | +0.55 | -0.62 | ||
| % Change | -1.41% | +1.25% | -3.93% | ||
| Volume | 629,700 | 406,200 | 732,000 | ||
| 20-Day Average Volume | 507,115 | 942,120 | 1,337,800 | ||
| Previous Close | 44.64 | 43.94 | 15.79 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 44.10 | 52.38 | 15.68 | ||
| 20-Day Raw Stochastic | 34.89% | 7.71% | 47.01% | ||
| 20-Day Relative Strength | 54.77 | 40.44 | 53.67 | ||
| Weighted Alpha | +112.74 | +7.00 | +55.89 | ||
| Today's Opinion | 88% Buy | 24% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 24% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.36% since 12/18/25 | +1.11% since 12/18/25 | +1.13% since 12/18/25 | ||
| Low | 41.58 on 12/19/25 | 42.95 on 12/23/25 | 14.91 on 12/26/25 | ||
| High | 44.85 on 12/24/25 | 47.12 on 12/19/25 | 16.30 on 12/23/25 | ||
| 1-Month | |||||
| %Chg | -13.64% since 11/26/25 | -32.27% since 11/26/25 | +7.59% since 11/26/25 | ||
| Low | 39.60 on 12/08/25 | 42.62 on 12/18/25 | 13.28 on 12/02/25 | ||
| High | 52.24 on 11/28/25 | 66.86 on 11/28/25 | 17.30 on 12/15/25 | ||
| 3-Month | |||||
| %Chg | +53.72% since 09/26/25 | -23.95% since 09/26/25 | +22.34% since 09/26/25 | ||
| Low | 26.38 on 10/14/25 | 42.62 on 12/18/25 | 10.41 on 11/07/25 | ||
| High | 52.24 on 11/28/25 | 66.92 on 10/31/25 | 17.30 on 12/15/25 | ||
| 6-Month | |||||
| %Chg | +134.59% since 06/26/25 | +49.90% since 06/26/25 | +31.91% since 06/26/25 | ||
| Low | 18.24 on 07/08/25 | 21.02 on 08/01/25 | 10.41 on 11/07/25 | ||
| High | 52.24 on 11/28/25 | 66.92 on 10/31/25 | 17.30 on 12/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 798,825 | 905,015 | 766,783 | ||
| Shares Outstanding, K | 18,151 | 20,342 | 50,546 | ||
| Annual Sales | 179,280,000 | 98,430,000 | 0 | ||
| Annual Net Income | 17,490,000 | -118,960,000 | -183,440,000 | ||
| Last Quarter Sales | 69,460,000 | 11,790,000 | 13,690,000 | ||
| Last Quarter Net Income | 27,900,000 | -35,520,000 | -49,480,000 | ||
| 60-Month Beta | 1.11 | 1.27 | -0.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.46 on 11/04/25 | -1.85 on 11/06/25 | -0.92 on 11/10/25 | ||
| Latest Earnings Date | 03/03/26 | 03/11/26 | 01/01/70 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 7.24 | 0.00 | 0.00 | ||